alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.2**

**CERTIFICATION      PURSUANT TO**

**18      U.S.C. §1350,**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

|   | 1.     | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of the Securities Exchange Act of 1934; and                                          |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                              |
|   | 2.     | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |

|   |                                                                             |                         |
|--------|----------------------------------------------------------------------------------|------------------------------|
|   |                                                                             | /s/                Heng Chuk |
|   | Heng                Chuk                                                         |
|   | Chief                Financial OfficerJune                7,                2007 |

----
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           4,078
<SECURITIES>                                         0
<RECEIVABLES>                                   40,896
<ALLOWANCES>                                     1,629
<INVENTORY>                                     69,490
<CURRENT-ASSETS>                               121,985
<PP&E>                                          18,297
<DEPRECIATION>                                   4,633
<TOTAL-ASSETS>                                 224,373
<CURRENT-LIABILITIES>                           42,566
<BONDS>                                         78,942
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           178
<OTHER-SE>                                     100,610
<TOTAL-LIABILITY-AND-EQUITY>                   224,373
<SALES>                                        152,902
<TOTAL-REVENUES>                               152,902
<CGS>                                          107,393
<TOTAL-COSTS>                                  107,393
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,748
<INCOME-PRETAX>                                (1,559)
<INCOME-TAX>                                     (111)
<INCOME-CONTINUING>                            (1,448)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,448)
<EPS-BASIC>                                      (0.8)
<EPS-DILUTED>                                    (0.8)


</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5

<CIK>                         0000882194
<NAME>                        Matrix Pharmaceutical, Inc.
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1996
<PERIOD-END>                                   DEC-31-1996
<CASH>                                         20,138
<SECURITIES>                                   38,997
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    758
<CURRENT-ASSETS>                               62,176
<PP&E>                                         21,527
<DEPRECIATION>                                 (4,375)
<TOTAL-ASSETS>                                 134,950
<CURRENT-LIABILITIES>                          7,715
<BONDS>                                        11,724
<COMMON>                                       222,256
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<OTHER-SE>                                     (106,745)
<TOTAL-LIABILITY-AND-EQUITY>                   134,950
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               35,748
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             1,088
<INCOME-PRETAX>                                (29,643)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (29,643)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (29,643)
<EPS-PRIMARY>                                  (1.48)
<EPS-DILUTED>                                  (1.48)
        


</TABLE>
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 17, 2019

RE: Product Exclusion Request Number USTR-2018-0025-2873

Cosan/USA: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/%2434_Billion_Exclusions_Gr

anted_September.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
[Federal Register Volume 60, Number 44 (Tuesday, March 7, 1995)]
[Notices]
[Page 12549]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-5471]



-----------------------------------------------------------------------

DEPARTMENT OF ENERGY
[Docket No. RP95-60-001]


Alabama-Tennessee Natural Gas Company; Refund Report

March 1, 1995.
    Take notice that Alabama-Tennessee Natural Gas Company (Alabama-
Tennessee) on January 10, 1995, tendered for filing with the Federal 
Energy Regulatory Commission (Commission) a report summarizing refunds 
disbursed on August 8, 1994, pursuant to the Commission-approved 
settlement in Docket No. RP92-237, et al. Alabama-Tennessee states that 
the refunds were disbursed by means of a credit to each customer's 
respective OBA imbalance amount existing at the time of the credit.
    All parties that have already filed comments or protests regarding 
the subject refund need not file in response to this notice.
    Any person desiring to protest said filing should file a protest 
with the Federal Energy Regulatory Commission, 825 North Capitol 
Street, NE., Washington, DC 20426, in accordance with Rule 211 of the 
Commission's Rules of Practice and Procedure (18 CFR 385.211). All such 
protests should be filed on or before March 8, 1995. Protests will be 
considered by the Commission in determining the appropriate action to 
be taken, but will not serve to make protestants parties to the 
proceeding. Copies of this filing are on file with the Commission and 
are available for public inspection.
Lois D. Cashell,
Secretary.
[FR Doc. 95-5471 Filed 3-6-95; 8:45 am]
BILLING CODE 6717-01-M
EXHIBIT 32.2  CERTIFICATION
PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Annual
Report on Form 10-K of HF Financial Corp. (the Company) for the fiscal
year ended June 30, 2008, as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Darrel L. Posegate, Executive
Vice President, Chief Financial Officer and Treasurer of the Company, certify,
pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:  (1)The Report fully
complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and  (2)The information
contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.   /s/
  Darrel L. PosegateDarrel L. Posegate,
  Executive Vice President,Chief Financial Officer and
  TreasurerDate:
  September 26,
  2008  
 *
  A
  signed original of this written statement required by Section 906 has
  been provided to HF Financial Corp. and will be retained by HF Financial
  Corp. and furnished to the Securities and Exchange Commission or its staff
  upon request.
COURT OF APPEALS

	SECOND DISTRICT OF TEXAS

	FORT WORTH

					NOS. 2-09-159-CR

						2-09-160-CR

LARRY D. CROWE JR.	          						APPELLANT

	V.

THE STATE OF TEXAS	STATE

	----------

	FROM COUNTY CRIMINAL COURT NO. 1 OF DENTON COUNTY

                                                 ----------

		MEMORANDUM OPINION1 AND JUDGMENT

	----------

	We have considered appellant’s “Motion To Dismiss Appeal.”  The motion complies with rule 42.2(a) of the rules of appellate procedure.  Tex. R. App. P. 42.2(a).  No decision of this court having been delivered before we received this motion, we grant the motion and dismiss the appeal.2  See Tex. R. App. P. 42.2(a), 43.2(f). 								

							       		PER CURIAM

PANEL: MCCOY, J.; CAYCE, C.J.; and MEIER, J.

DO NOT PUBLISH

Tex. R. App. P. 47.2(b)

DELIVERED: September 17, 2009
<TABLE> <S> <C>


<ARTICLE>                     5

<CIK>                          0001059366
<NAME>                         NBG Radio Network, Inc.
<MULTIPLIER>                   1
<CURRENCY>                     USD

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>               NOV-30-2000
<PERIOD-START>                  DEC-01-1999
<PERIOD-END>                    FEB-29-2000
<EXCHANGE-RATE>                           1
<CASH>                                                 340,742
<SECURITIES>                                           468,750
<RECEIVABLES>                                        2,691,601
<ALLOWANCES>                                             1,200
<INVENTORY>                                             26,557
<CURRENT-ASSETS>                                     5,818,820
<PP&E>                                                 312,266
<DEPRECIATION>                                         119,413
<TOTAL-ASSETS>                                       7,552,328
<CURRENT-LIABILITIES>                                2,477,384
<BONDS>                                                      0
<PREFERRED-MANDATORY>                                        0
<PREFERRED>                                                  0
<COMMON>                                                12,160
<OTHER-SE>                                           6,708,412
<TOTAL-LIABILITY-AND-EQUITY>                         7,552,328
<SALES>                                              1,924,732
<TOTAL-REVENUES>                                     1,929,983
<CGS>                                                  574,498
<TOTAL-COSTS>                                        1,165,700
<OTHER-EXPENSES>                                             0
<LOSS-PROVISION>                                             0
<INTEREST-EXPENSE>                                         633
<INCOME-PRETAX>                                        189,785
<INCOME-TAX>                                                 0
<INCOME-CONTINUING>                                    189,785
<DISCONTINUED>                                               0
<EXTRAORDINARY>                                              0
<CHANGES>                                                    0
<NET-INCOME>                                           189,785
<EPS-BASIC>                                               (.02)
<EPS-DILUTED>                                             (.01)



</TABLE>
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4261 Engrossed in Senate (ES)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
117th CONGRESS
  2d Session
                                S. 4261

_______________________________________________________________________

                                 AN ACT

 
 To suspend duties and other restrictions on the importation of infant 
formula to address the shortage of infant formula in the United States, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Fixing Our Regulatory Mayhem 
Upsetting Little Americans Act'' or the ``FORMULA Act''.

SEC. 2. DUTY-FREE TREATMENT OF IMPORTS OF INFANT FORMULA.

    (a) In General.--During the 90-day period beginning on the date of 
the enactment of this Act, infant formula shall enter the United States 
free of duty and free of quantitative limitation.
    (b) Infant Formula Defined.--In this section, the term ``infant 
formula'' has the meaning given that term in section 201(z) of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(z)).

            Passed the Senate June 23, 2022.

            Attest:

                                                             Secretary.
117th CONGRESS

  2d Session

                                S. 4261

_______________________________________________________________________

                                 AN ACT

 To suspend duties and other restrictions on the importation of infant 
formula to address the shortage of infant formula in the United States, 
                        and for other purposes.
```
Exhibit 23.1
**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**
      We consent to the incorporation by reference in the Registration Statements on Form S**-**8 FileNo. 333**-**98341, 333-69094, 333-63687, 333-24169, and 333-24167 of Diametrics Medical, Inc. of ourreport dated April 28, 2005 (except as to Note 17, as to which the date is May 2, 2005), whichappears on page 21 of this annual report on Form 10-K for the year ended December 31, 2004.
/s/ VIRCHOW, KRAUSE & COMPANY, LLP
Minneapolis, Minnesota
Exhibit 32.2
 
  1.
    
    The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable,
of the Securities Exchange Act of 1934; and2.
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company.
 /s/ Howard M. SipznerHoward M. SipznerExecutive Vice President and Chief Financial Officer
Date: May 8, 2009 
 *
    
    A signed original of this written statement required by Section 906 has been provided to
Brandywine Realty Trust and will be retained by Brandywine Realty Trust and furnished to the
Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-26-1998
<PERIOD-START>                             DEC-28-1998
<PERIOD-END>                               SEP-26-1998
<CASH>                                           3,109
<SECURITIES>                                         0
<RECEIVABLES>                                  103,060
<ALLOWANCES>                                     3,524
<INVENTORY>                                    104,618
<CURRENT-ASSETS>                               232,390
<PP&E>                                         174,821
<DEPRECIATION>                                  65,580
<TOTAL-ASSETS>                                 401,605
<CURRENT-LIABILITIES>                          151,490
<BONDS>                                        323,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            59
<OTHER-SE>                                   (100,090)
<TOTAL-LIABILITY-AND-EQUITY>                   401,605
<SALES>                                        319,041
<TOTAL-REVENUES>                               319,041
<CGS>                                          223,808
<TOTAL-COSTS>                                  223,808
<OTHER-EXPENSES>                               121,413
<LOSS-PROVISION>                                   539
<INTEREST-EXPENSE>                              19,161
<INCOME-PRETAX>                               (45,341)
<INCOME-TAX>                                     (161)
<INCOME-CONTINUING>                           (45,180)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (45,180)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
**EXHIBIT
      24.1**





POWER
      OF
      ATTORNEY








KNOW
      ALL
      PERSONS BY THESE PRESENTS, that each person whose signature appears below,
      as
      directors of SpatiaLight, Inc., hereby constitutes and appoints David F. Hakala
      as his or her true and lawful attorney-in-fact and agent, with full power of
      substitution and resubstitution, for him or her and in his or her name, place
      and stead, in any and all capacities to sign on behalf of each of the
      undersigned an Annual Report on Form 10-K for the fiscal year ended December
      31,
      2006 pursuant to Section 13 of the Securities Exchange Act of 1934 and to sign
      any and all amendments to such Annual Report, and to file the same, with all
      exhibits thereto, and other documents in connection therewith including, without
      limitation, a Form 12b-25 with the Securities and Exchange Commission, granting
      to said attorney-in-fact, and each of them, full power and authority to do
      so
      and to perform each and every act and thing requisite and necessary to be done
      in and about the premises, as fully to all intents and purposes as the
      undersigned might or could do in person, hereby ratifying and confirming all
      that said attorney-in-fact or substitutes may lawfully do or cause to be done
      by
      virtue thereof.





This
      Power of Attorney may be executed in multiple counterparts, each of which shall
      be deemed an original and all of which, when taken together, shall constitute
      one and the same document.





IN
      WITNESS WHEREOF, the undersigned have executed this Power of Attorney as of
      the 15th
      day
      of March 2007 .




Signature
              Title/s/ DAVID
                F.
                HAKALA
              Chairman
                of
                the Board of DirectorsDavid
                F. Hakala/s/ROBERT C. MUNRO
                Robert
                C. Munro
              Director/s/CLAUDE PIAGET
                Claude
                Piaget
              Director/s/JERILYN KESSEL
                Jerilyn
                Kessel
              Director/s/HERBERT EHRENTHAL
                Herbert
                Ehrenthal
              Director


96
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Obesity and Metabolism Research: Davis, CA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    Laboratories
                        Bennett Group
                                    Huang Group
                                    Keim Group
                                    Laugero Group
                                    Newman GroupSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Davis, California Western Human Nutrition Research Center Obesity and Metabolism Research Research





- ARS National Programs
- Search for a scientific manuscript
- Search for a research project
- ARS Software
- Programs and Projects
- Collaborations
- Subjects of Investigation
- Publications

Research Projects Subjects of Investigation at this LocationEach ARS research project has related subjects of investigation.  Listed below are the subjects of investigation currently conducted at this location.
Clicking on a subject of investigation will list the research projects within that  subject of investigation.Subjects of Investigation
                            Individuals (as workers, consumers, members of society)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
[No. 24580.

*En Banc.*

February 9, 1934.]

#### The State of Washington, *on the Relation of Joseph L. O’Brien et al., Plaintiff,*v. The Superior Court for King County *et al.,*Respondents.1

*Edward, L. Cochrane*and *J. H. Lynch,*for relators.

*James Tynan,*for respondents.

1

 cReported in 29 P. (2d) 1119.

On Rehearing.

Per Curiam.

— Upon a rehearing *En Banc,*the court adheres to the Departmental opinion heretofore filed herein, and reported in 173 Wash. 679, 24 P. (2d) 117.